Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients

Sedimbi, S K ; Luo, X R ; Sanjeevi, C B ; Lernmark, Ake LU orcid ; Landin-Olsson, Mona LU ; Arnqvist, Hans ; Bjorck, Elizabeth ; Nystrom, Lennarth ; Ohlson, Lars Olof and Schersten, Bengt , et al. (2007) In Genes and Immunity 8(6). p.518-521
Abstract
SUMO4 M55V, located in IDDM5, has been a focus for debate because of its association to type I diabetes (TIDM) in Asians but not in Caucasians. The current study aims to test the significance of M55V association to TIDM in a large cohort of Swedish Caucasians, and to test whether M55V is associated in those carrying human leukocyte antigen (HLA) class II molecules. A total of 673 TIDM patients and 535 age- and sex-matched healthy controls were included in the study. PCR-RFLP was performed to identify the genotype and allele variations. Our data suggest that SUMO4 M55V is not associated with susceptibility to TIDM by itself. When we stratified our patients and controls based on heterozygosity for HLA-DR3/DR4 and SUMO4 genotypes, we found... (More)
SUMO4 M55V, located in IDDM5, has been a focus for debate because of its association to type I diabetes (TIDM) in Asians but not in Caucasians. The current study aims to test the significance of M55V association to TIDM in a large cohort of Swedish Caucasians, and to test whether M55V is associated in those carrying human leukocyte antigen (HLA) class II molecules. A total of 673 TIDM patients and 535 age- and sex-matched healthy controls were included in the study. PCR-RFLP was performed to identify the genotype and allele variations. Our data suggest that SUMO4 M55V is not associated with susceptibility to TIDM by itself. When we stratified our patients and controls based on heterozygosity for HLA-DR3/DR4 and SUMO4 genotypes, we found that presence of SUMO4 GG increased further the relative risk conferred by HLA-DR3/DR4 to TIDM, whereas SUMO4 AA decreased the risk. From the current study, we conclude that SUMO4 M55V is associated with TIDM in association with high-risk HLA-DR3 and DR4, but not by itself. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Genes and Immunity
volume
8
issue
6
pages
518 - 521
publisher
Nature Publishing Group
external identifiers
  • pmid:17554341
  • scopus:34548438102
  • pmid:17554341
ISSN
1476-5470
DOI
10.1038/sj.gene.6364406
language
English
LU publication?
yes
id
edc9938a-8598-40f9-b7ca-1aad6b787cf7 (old id 1140507)
date added to LUP
2016-04-04 08:34:51
date last changed
2024-10-12 18:03:41
@article{edc9938a-8598-40f9-b7ca-1aad6b787cf7,
  abstract     = {{SUMO4 M55V, located in IDDM5, has been a focus for debate because of its association to type I diabetes (TIDM) in Asians but not in Caucasians. The current study aims to test the significance of M55V association to TIDM in a large cohort of Swedish Caucasians, and to test whether M55V is associated in those carrying human leukocyte antigen (HLA) class II molecules. A total of 673 TIDM patients and 535 age- and sex-matched healthy controls were included in the study. PCR-RFLP was performed to identify the genotype and allele variations. Our data suggest that SUMO4 M55V is not associated with susceptibility to TIDM by itself. When we stratified our patients and controls based on heterozygosity for HLA-DR3/DR4 and SUMO4 genotypes, we found that presence of SUMO4 GG increased further the relative risk conferred by HLA-DR3/DR4 to TIDM, whereas SUMO4 AA decreased the risk. From the current study, we conclude that SUMO4 M55V is associated with TIDM in association with high-risk HLA-DR3 and DR4, but not by itself.}},
  author       = {{Sedimbi, S K and Luo, X R and Sanjeevi, C B and Lernmark, Ake and Landin-Olsson, Mona and Arnqvist, Hans and Bjorck, Elizabeth and Nystrom, Lennarth and Ohlson, Lars Olof and Schersten, Bengt and Ostman, Jan and Aili, M and Baath, L E and Carlsson, E and Edenwall, H and Forsander, G}},
  issn         = {{1476-5470}},
  language     = {{eng}},
  number       = {{6}},
  pages        = {{518--521}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Genes and Immunity}},
  title        = {{SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients}},
  url          = {{http://dx.doi.org/10.1038/sj.gene.6364406}},
  doi          = {{10.1038/sj.gene.6364406}},
  volume       = {{8}},
  year         = {{2007}},
}